目次

Table of Contents

1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive landscape

2 Market Overview
2.1. Market definition
2.2. Market analysis

3 Market Data
3.1. Market value

4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation

5 Market Outlook
5.1. Market value forecast

6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 Competitive Landscape
7.1. Who are the key players?
7.2. What strategies do the key players follow?
7.3. What have been the most recent market developments?

8 Company Profiles
8.1. AstraZeneca Plc
8.2. GSK plc
8.3. Oxford Nanopore Technologies Plc
8.4. Immunocore Holdings Plc

9 Macroeconomic Indicators
9.1. Country data

10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine

List of Tables
Table 1: United Kingdom biotechnology industry value: $ million, 2019-24
Table 2: United Kingdom biotechnology industry category segmentation: % share, by value, 2019-24
Table 3: United Kingdom biotechnology industry category segmentation: $ million, 2019-24
Table 4: United Kingdom biotechnology industry geography segmentation: $ million, 2024
Table 5: United Kingdom biotechnology industry value forecast: $ million, 2024-29
Table 6: AstraZeneca Plc: Key Facts
Table 7: AstraZeneca Plc: Annual Financial Ratios
Table 8: AstraZeneca Plc: Key Employees
Table 9: GSK plc: Key Facts
Table 10: GSK plc: Annual Financial Ratios
Table 11: GSK plc: Key Employees
Table 12: Oxford Nanopore Technologies Plc: Key Facts
Table 13: Oxford Nanopore Technologies Plc: Annual Financial Ratios
Table 14: Oxford Nanopore Technologies Plc: Key Employees
Table 15: Oxford Nanopore Technologies Plc: Key Employees Continued
Table 16: Immunocore Holdings Plc: Key Facts
Table 17: Immunocore Holdings Plc: Annual Financial Ratios
Table 18: Immunocore Holdings Plc: Key Employees
Table 19: United Kingdom Size of Population (Million), 2019-24
Table 20: United Kingdom Real GDP (Constant 2010 Prices, $ Billion), 2019-24
Table 21: United Kingdom GDP (Current Prices, $ Billion), 2019-24
Table 22: United Kingdom Inflation, 2019-24
Table 23: United Kingdom Consumer Price Index (Absolute), 2019-24
Table 24: United Kingdom Exchange Rate, 2019-24

List of Figures
Figure 1: United Kingdom biotechnology industry value: $ million, 2019-24
Figure 2: United Kingdom biotechnology industry category segmentation: $ million, 2019-24
Figure 3: United Kingdom biotechnology industry geography segmentation: % share, by value, 2024
Figure 4: United Kingdom biotechnology industry value forecast: $ million, 2024-29
Figure 5: Forces driving competition in the biotechnology industry in the United Kingdom, 2024
Figure 6: Drivers of buyer power in the biotechnology industry in the United Kingdom, 2024
Figure 7: Drivers of supplier power in the biotechnology industry in the United Kingdom, 2024
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in the United Kingdom, 2024
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in the United Kingdom, 2024
Figure 10: Drivers of degree of rivalry in the biotechnology industry in the United Kingdom, 2024